Kubota Pharma FY Loss Y676.00M Vs Loss Y1.33B

Like
Comment
Favorite

Kubota Pharma FY Loss Y676.00M Vs Loss Y1.33B

Dow Jones03-19 14:30

    Kubota Pharmaceutical Holdings Co. Ltd. (4596.TO) 
    Japan 
    Year Ended December 31 
GROUP                2025                   2024 
Revenue              Y21.00 mln       Y27.00 mln 
Operating Profit     (Y895.00 mln)   (Y1.35 bln) 
Pretax Profit        (Y676.00 mln)   (Y1.33 bln) 
Net Profit           (Y676.00 mln)   (Y1.33 bln) 
Per share 
  Earnings           (Y10.59)           (Y23.65) 
  Diluted Earnings   (Y10.59)           (Y23.65) 
 
    Figures in parentheses are losses. 
 
    Results are based on IFRS accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

March 19, 2026 02:30 ET (06:30 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2620219016?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 14:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620219016","market":"nz","top_or_hot":-1,"title":"Kubota Pharma FY Loss Y676.00M Vs Loss Y1.33B","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    Kubota Pharmaceutical Holdings Co. Ltd. (4596.TO) \n    Japan \n    Year Ended December 31 \nGROUP                2025                   2024 \nRevenue              Y21.00 mln       Y27.00 mln \nOperating Profit     (Y895.00 mln)   (Y1.35 bln) \nPretax Profit        (Y676.00 mln)   (Y1.33 bln) \nNet Profit           (Y676.00 mln)   (Y1.33 bln) \nPer share \n  Earnings           (Y10.59)           (Y23.65) \n  Diluted Earnings   (Y10.59)           (Y23.65) \n \n    Figures in parentheses are losses. \n \n    Results are based on IFRS accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 19, 2026 02:30 ET (06:30 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kubota Pharma FY Loss Y676.00M Vs Loss Y1.33B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKubota Pharma FY Loss Y676.00M Vs Loss Y1.33B\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-19 14:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    Kubota Pharmaceutical Holdings Co. Ltd. (4596.TO) \n    Japan \n    Year Ended December 31 \nGROUP                2025                   2024 \nRevenue              Y21.00 mln       Y27.00 mln \nOperating Profit     (Y895.00 mln)   (Y1.35 bln) \nPretax Profit        (Y676.00 mln)   (Y1.33 bln) \nNet Profit           (Y676.00 mln)   (Y1.33 bln) \nPer share \n  Earnings           (Y10.59)           (Y23.65) \n  Diluted Earnings   (Y10.59)           (Y23.65) \n \n    Figures in parentheses are losses. \n \n    Results are based on IFRS accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 19, 2026 02:30 ET (06:30 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2620219016","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620219016","pubTimestamp":1773901800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"久保田制药财年亏损Y676.00 M vs亏损Y1.33B","themeId":"8603dabb40994e59ac78c04c930c0d49","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Kubota Pharmaceutical Holdings Co. Ltd. (4596.TO) \n    Japan \n    Year Ended December 31 \nGROUP                2025                   2024 \nRevenue              Y21.00 mln       Y27.00 mln \nOperating Profit     (Y895.00 mln)   (Y1.35 bln) \nPretax Profit        (Y676.00 mln)   (Y1.33 bln) \nNet Profit           (Y676.00 mln)   (Y1.33 bln) \nPer share \n  Earnings           (Y10.59)           (Y23.65) \n  Diluted Earnings   (Y10.59)           (Y23.65) \n \n    Figures in parentheses are losses. \n \n    Results are based on IFRS accounting standards. \n\n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 02:30 ET (06:30 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}